These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 26033159)

  • 1. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
    Vedanayagam J; Chatila WK; Aksoy BA; Majumdar S; Skanderup AJ; Demir E; Schultz N; Sander C; Lai EC
    Nat Commun; 2019 Aug; 10(1):3682. PubMed ID: 31417090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse.
    Hong P; Jiang M; Li H
    Glia; 2014 Dec; 62(12):2044-60. PubMed ID: 25043492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    de Kock L; Druker H; Weber E; Hamel N; Traubici J; Malkin D; Arseneau J; Stewart CJ; Bouron-Dal Soglio D; Priest JR; Foulkes WD
    Hum Pathol; 2015 Jun; 46(6):917-22. PubMed ID: 25836323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
    Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
    Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome.
    de Kock L; Wang YC; Revil T; Badescu D; Rivera B; Sabbaghian N; Wu M; Weber E; Sandoval C; Hopman SM; Merks JH; van Hagen JM; Bouts AH; Plager DA; Ramasubramanian A; Forsmark L; Doyle KL; Toler T; Callahan J; Engelenberg C; Bouron-Dal Soglio D; Priest JR; Ragoussis J; Foulkes WD
    J Med Genet; 2016 Jan; 53(1):43-52. PubMed ID: 26475046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
    Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.
    Pugh TJ; Yu W; Yang J; Field AL; Ambrogio L; Carter SL; Cibulskis K; Giannikopoulos P; Kiezun A; Kim J; McKenna A; Nickerson E; Getz G; Hoffher S; Messinger YH; Dehner LP; Roberts CW; Rodriguez-Galindo C; Williams GM; Rossi CT; Meyerson M; Hill DA
    Oncogene; 2014 Nov; 33(45):5295-302. PubMed ID: 24909177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
    Wang Y; Tao VL; Shin CY; Salamanca C; Chen SY; Chow C; Köbel M; Ben-Neriah S; Farnell D; Steidl C; Mcalpine JN; Gilks CB; Huntsman DG
    PLoS One; 2020; 15(10):e0240412. PubMed ID: 33052929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
    Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
    J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A forward genetic screen to study mammalian RNA interference: essential role of RNase IIIa domain of Dicer1 in 3' strand cleavage of dsRNA in vivo.
    Ohishi K; Nakano T
    FEBS J; 2012 Mar; 279(5):832-43. PubMed ID: 22221880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
    Wang Y; Chen SY; Ta M; Senz J; Tao LV; Thornton S; Tamvada N; Yang W; Moscovitz Y; Li E; Guo J; Shen C; Douglas JM; Ei-Naggar AM; Kommoss FKF; Underhill TM; Singh N; Gilks CB; Morin GB; Huntsman DG
    Cancer Res; 2023 Nov; 83(21):3517-3528. PubMed ID: 37494476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic DICER1 mutations occur in Wilms tumours.
    Wu MK; Sabbaghian N; Xu B; Addidou-Kalucki S; Bernard C; Zou D; Reeve AE; Eccles MR; Cole C; Choong CS; Charles A; Tan TY; Iglesias DM; Goodyer PR; Foulkes WD
    J Pathol; 2013 Jun; 230(2):154-64. PubMed ID: 23620094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.